Cellectis S.A. ADR (CLLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CLLS | AMGN | BMY | VRTX | GILD |
| Company | Cellectis S.A. ADR | Amgen Inc | Bristol-Myers Squibb Company | Vertex Pharmaceutic | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 2.14 | 279.00 | 58.82 | 464.81 | 91.44 |
| High | 2.15 | 282.69 | 59.51 | 470.42 | 92.89 |
| Low | 2.09 | 278.00 | 58.78 | 462.01 | 91.44 |
| Last | 2.13 | 280.07 | 59.27 | 464.56 | 92.41 |
| Change | -0.01 | +0.06 | +0.53 | -2.51 | +1.06 |
| % Change | -0.47% | +0.02% | +0.90% | -0.54% | +1.16% |
| Volume | 41,200 | 6,622,700 | 7,064,800 | 1,006,900 | 5,527,200 |
| 20-Day Average Volume | 93,200 | 4,136,435 | 12,515,780 | 1,472,315 | 7,580,835 |
| Previous Close | 2.14 | 280.01 | 58.74 | 467.07 | 91.35 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.89 | 301.56 | 57.22 | 476.48 | 91.41 |
| 20-Day Raw Stochastic | 94.51% | 31.61% | 75.93% | 26.12% | 49.38% |
| 20-Day Relative Strength | 59.01% | 33.54% | 62.95% | 46.65% | 59.34% |
| Weighted Alpha | -27.52 | -4.63 | +28.20 | +23.46 | +28.23 |
| Today's Opinion | 40% Sell | 72% Sell | 100% Buy | 8% Sell | 100% Buy |
| Previous Opinion | 40% Sell | 72% Sell | 100% Buy | 8% Sell | 96% Buy |
| Last Month's Opinion | 88% Sell | 8% Buy | 72% Buy | 8% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +11.52% since 11/20/24 | -2.71% since 11/20/24 | +2.40% since 11/20/24 | +2.95% since 11/20/24 | +4.26% since 11/20/24 |
| Low | 1.82 on 11/21/24 | 257.80 on 11/26/24 | 57.47 on 11/21/24 | 445.00 on 11/21/24 | 88.07 on 11/21/24 |
| High | 2.15 on 11/27/24 | 297.32 on 11/25/24 | 60.68 on 11/25/24 | 470.42 on 11/27/24 | 92.89 on 11/27/24 |
| 1-Month | |||||
| %Chg | +14.52% since 10/25/24 | -11.64% since 10/25/24 | +14.16% since 10/25/24 | -2.75% since 10/25/24 | +3.83% since 10/25/24 |
| Low | 1.70 on 11/07/24 | 257.80 on 11/26/24 | 51.81 on 10/28/24 | 445.00 on 11/21/24 | 86.08 on 11/19/24 |
| High | 2.15 on 11/27/24 | 328.25 on 11/08/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| 3-Month | |||||
| %Chg | -10.50% since 08/27/24 | -14.33% since 08/27/24 | +23.17% since 08/27/24 | -3.28% since 08/27/24 | +20.01% since 08/27/24 |
| Low | 1.70 on 11/07/24 | 257.80 on 11/26/24 | 47.55 on 09/09/24 | 445.00 on 11/21/24 | 77.23 on 08/28/24 |
| High | 2.42 on 08/28/24 | 339.17 on 09/23/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| 6-Month | |||||
| %Chg | -24.47% since 05/24/24 | -8.43% since 05/24/24 | +43.72% since 05/24/24 | +1.67% since 05/24/24 | +40.70% since 05/24/24 |
| Low | 1.70 on 11/07/24 | 257.80 on 11/26/24 | 39.35 on 07/05/24 | 435.57 on 05/30/24 | 62.07 on 05/31/24 |
| High | 2.81 on 05/31/24 | 346.85 on 07/25/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 118,394 | 150,546,880 | 120,210,048 | 119,637,672 | 115,167,440 |
| Shares Outstanding, K | 55,584 | 537,533 | 2,028,177 | 257,529 | 1,246,266 |
| Annual Sales | 9,190,000 | 28,190,000,000 | 45,006,000,000 | 9,869,200,000 | 27,116,000,000 |
| Annual Net Income | -101,060,000 | 6,717,000,000 | 8,025,000,000 | 3,619,600,000 | 5,665,000,000 |
| Last Quarter Sales | 18,050,000 | 8,503,000,000 | 11,892,000,000 | 2,771,900,000 | 7,545,000,000 |
| Last Quarter Net Income | -23,060,000 | 2,830,000,000 | 1,211,000,000 | 1,045,400,000 | 1,253,000,000 |
| 60-Month Beta | 3.10 | 0.60 | 0.44 | 0.39 | 0.17 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.23 on 11/04/24 | 5.58 on 10/30/24 | 1.80 on 10/31/24 | 4.38 on 11/04/24 | 2.02 on 11/06/24 |
| Latest Earnings Date | 11/04/24 | 10/30/24 | 10/31/24 | 11/04/24 | 11/06/24 |
| Most Recent Dividend | N/A | 2.250 on 11/18/24 | 0.600 on 10/04/24 | N/A | 0.770 on 09/13/24 |
| Next Ex-Dividends Date | N/A | 11/18/24 | 10/04/24 | N/A | 12/13/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.57 | 50.21 | 0.00 | 20.62 |